Trial · NCT07138560
BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
NCT07138560, Phase 4, Recruiting, The Cleveland Clinic
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease. Trials, record NCT07138560. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07138560
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
- NCT number
- NCT07138560
- Status
- Recruiting
- Phases
- Phase 4
- Enrollment
- 22 participants, estimated
- Lead sponsor
- The Cleveland Clinic
- Conditions
- Parkinson Disease
- Interventions
- CREXONT ER
- First posted
- 2025-08-24
- Last updated
- 2026-10-15
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Primary Endpoint | 8 weeks | Mean change in the average duration of good on-time from baseline to end of study |
| Secondary | Secondary Endpoint | 8 weeks | Mean change in the average 'slowness' scores as measured by KinesiaU |
| Secondary | Secondary Endpoint | 8 weeks | Mean change in time spent with tremor as measured by KinesiaU |
| Secondary | Secondary Endpoint | 8 weeks | Mean change in the average tremor scores as measured by KinesiaU |
| Secondary | Secondary Endpoint | 8 weeks | Mean change in time spent with dyskinesia as measured by KinesiaU |
| Secondary | Secondary Endpoint | 8 weeks | Mean change in the continuous on time as measured by KinesiaU |
| Other | Exploratory Endpoints | 8 weeks | Mean difference between KinesiaU and PD diary measurements of change in good on-time from baseline to end of study |
| Other | Exploratory Endpoint | 8 weeks | Difference in the Patient Global Impression of Change from baseline to end of study. |
| Other | Exploratory Endpoint | 8 weeks | Difference between Non-Motor Fluctuation Assessment Questionnaire from baseline to end of study. |
| Other | Exploratory Endpoint | 8 weeks | The average time (in weeks) taken to reach the final dose. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07138560
GET https://conductscience.org/api/trials/v1/NCT07138560/registered